On June 14, 2025, during the BIO International Convention, AHEA was honored to co-host the Executive Workshop at PwC Boston Headquarters, in partnership with PwC, IntelliPro, BayHelix, and MSQ Ventures.
This closed-door, invite-only roundtable convened senior leaders from multinational pharma, biotech, legal, and investment sectors to discuss global expansion strategies in an increasingly complex international landscape. Topics ranged from tax planning and deal structuring to cross-border compliance and NewCo development models.
🌍 Session Highlights & Speakers:
🔹 Navigating Tax Strategies in Uncertain Times How to build agile tax structures amid global economic and political shifts → Speaker: @Seamus Jiang, Managing Director, PwC
🔹 Pharma Partnering Insight from Asia to Global Strategic approaches of multinational pharma companies in Asia → Speaker: @Harm-Jan Borgeld, Head of Asia Pharma Partnering, Roche
🔹 Deal Structure & Contract Law Designing and implementing legal frameworks in cross-border transactions → Speaker: @Wendy Pan, Partner, Goodwin
🔹 Strategic Cooperation and Innovative Expansion Paths Building long-term value through partnership and global growth → Speaker: @Alex Cogdill, Head of Strategic Initiatives, Global BD, Daiichi Sankyo US
🔹 Strategic Investment & NewCo Trends Exploring the NewCo model and investment pathways → Speaker: @Echo Hindle-Yang, CEO, MSQ Ventures
🔹 Pipeline Search & Evaluation Strategy How big pharma evaluates early-stage assets and drives collaboration → Speaker: @Nikhil Mutyal, Head of Search & Evaluation, AstraZeneca
🤝 The Executive Workshop served as a high-impact platform for candid discussion, cross-functional exchange, and collaborative ideation among global leaders shaping the future of the life sciences industry.
🌐 At AHEA, we are committed to bridging global talent, capital, and strategic expertise. This workshop exemplified our mission to foster deeper cross-border engagement and advance globalization in biopharma.
On January 11, 2026, during J.P. Morgan Healthcare Week, the American Healthcare Executive Association (AHEA) convened senior leaders from across global biopharma in San Francisco for the 2026 Global Biopharma Leadership Forum — creating a trusted platform for strategic exchange ahead of the industry’s most influential gathering of the year.
On January 11, 2026, during J.P. Morgan Healthcare Week, American Healthcare Executive Association was proud to partner with bioSeedin to co-host the BIOseedin Winter Innovation Partnering Summit in San Francisco.
On June 15, 2025, AHEA was proud to co-host the Global Biopharma Leadership Forum at Harvard Medical School, alongside IntelliPro, BayHelix Group, CSSA@HMS, and MSQ Ventures, with generous support from BioCentury and UHY.
On June 14, 2025, during the BIO International Convention, AHEA was honored to co-host the Executive Workshop at PwC Boston Headquarters, in partnership with PwC, IntelliPro, BayHelix, and MSQ Ventures.
It was a pleasure to co-host the “NewCo & Out-Licensing” forum with Jones Day and IntelliPro bringing together leaders from biotech, pharma, and investment to explore cross-border collaboration and global expansion strategies.
We are thrilled to announce the resounding success of the AHEA Summit 2024, held in conjunction with JPM2024. This event has marked a significant milestone in our journey towards healthcare innovation and global collaboration.
contact@ahea.io